Welcome to join our lunch webinar on August 19. This time on when new antidepressants can be expected to arrive in Europe and future diagnostic methods. We welcome our expert speaker, Professor Henrik Zetterberg who will share his extensive knowledge and research in neurochemistry as well as his experience as a senior physician at the University of Gothenburg.
Alzheimer's disease is a growing problem worldwide, and the need for effective treatments is more urgent than ever. During this lecture, we will explore the timeline and challenges of bringing antidementia drugs to Europe. We will also learn about the regulatory environment between the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA), and see how these differences affect the availability of new treatments on both sides of the Atlantic.
Accurate and early diagnosis of Alzheimer's disease is crucial for effective treatment. The future of diagnostics is moving towards less invasive methods, such as blood tests, which could revolutionize the way we diagnose dementia. Currently, spinal fluid analysis is the gold standard for diagnosis. During the lecture, we will gain insights into the differences between these two diagnostic methods, discuss their advantages, limitations and potential roles in the future management of Alzheimer's disease.
Professor Zetterberg is a leader in neurochemistry with a particular focus on Alzheimer's disease. His research and contributions to that science are enormously valuable, and his insights will provide a deeper understanding of the future treatment and diagnosis of Alzheimer's disease.
Don't miss this opportunity to learn about the latest advances in Alzheimer's research and what they mean for patients and caregivers in Europe.
When? August 1912:00-13:00
Where? Digitally via Teams and is free of charge
You can register at the following link:
https://forms.gle/xHKVH5dtmP9VnzhGA
When you register, you will receive a confirmation email with a video link (check your spam folder, it sometimes ends up there)
Please spread the invitation to colleagues and others who you think might be interested in participating.
A warm welcome!
